TABLE 2.

The outcomes and adverse events of radiofrequency ablation for Meige’s syndrome.

Pt.	Diagnosis and relevant abnormal symptoms	Follow up time	Treatment effect and recurrence	Adverse events	Adverse events lasted
1	BDS (blepharospasm)	31 months	Recurrence at the 18th month	Facial paralysis class II	Disappeared 2 months later
2	BDS (blepharospasm)	24 months	Recurrence at the 22th month	Facial paralysis class III	Disappeared 3 months later
3	B-ODS (blepharospasm combined with oromandibular dystonia)	9 months	No recurrence	Facial paralysis class III	Disappeared 3 months later; skin numbness of mandibular, lasted for 9 months
4	BDS (blepharospasm)	4 months	No recurrence	Facial paralysis class II	Disappeared 2 months later
5	B-ODS (blepharospasm combined with oromandibular dystonia)	4 months	No recurrence	Facial paralysis class II	Disappeared 3 months later; skin numbness of mandibular; lasted to now
6	BDS (blepharospasm)	3 months	No recurrence	Facial paralysis class III	Disappeared 2 months later
7	ODS (oromandibular dystonia)	3 months	No recurrence	Skin numbness of mandibular,	Numbness lasted to now
8	BDS (blepharospasm)	2 months	No recurrence	Facial paralysis class III, restored to class II	Lasted to now
9	BDS (blepharospasm)	2 months	No recurrence	Facial paralysis class II	Lasted to now
10	BDS (blepharospasm)	1 months	No recurrence	Facial paralysis class III	Lasted to now

BDS, blepharospasm dystonia syndrome; ODS, oromandibular dystonia syndrome; B-ODS, blepharospasm combined with oromandibular dystonia syndrome.